When was Quibim founded?

Quibim was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Quibim located?

Quibim is headquartered in Valencia, Spain.

Who is the current CEO of Quibim?

Angel Alberich-Bayarri of Quibim.

Which legal entities is Quibim associated with?

Quibim is associated with QUIBIM LIMITED and 2 others.

How many employees does Quibim have?

As of Jul 31, 2026, the latest employee count at Quibim is 117.

Is Quibim a funded company?

Quibim is a funded company, having raised a total of $60M across 15 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 27, 2016.

When was the latest funding round of Quibim?

Quibim's latest funding was a $***** Series A round on Jan 28, 2025, with participation from 11 investors.

Where does Quibim rank among its competitors?

Quibim ranks 2nd amongst 115 active competitors, of which 23 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Modicus Prime, which secured $4.5M in May, 2026.

Who are the top competitors of Quibim?

Quibim's top competitors include AOA, Median and Panakeia. Among them, Modicus Prime secured the most recent funding round in May, 2026.

Quibim - 2026 Company Profile, Team, Funding & Competitors

Quibim is a series A company based in Valencia (Spain), founded in 2015 by Angel Alberich-Bayarri and Luis Marti-Bonmati. It operates as a Developer of medical imaging software for radiomics and biomarker analysis. Quibim has raised $60M in funding from investors like Amadeus Capital, Angels Capital and Asabys Partners. The company has 115 active competitors, including 23 funded and 5 that have exited. Its top competitors include companies like AOA, Median and Panakeia.

Company Details

Developer of medical imaging software for radiomics and biomarker analysis. This software extracts quantitative features from medical images to support clinical research and diagnostic workflows. The platform manages, indexes, and harmonizes imaging data while integrating with electronic health records. It provides automated tools for analyzing specific organ systems, including the prostate, brain, liver, breast, and lung. These tools facilitate the calculation of volumetric data and the identification of imaging patterns to assist in disease classification and monitoring. The technology functions as a cloud-based system for processing and storing medical imaging data in compliance with data security standards.

Website: quibim.com
Social
Email ID: *****@quibim.com
Phone Number: +34 **********

Key Metrics

Founded Year

2015

Location

Valencia, Spain

Stage

Series A

Total Funding

$60M in 15 rounds

Latest Funding Round

Series A, Jan 28, 2025, $*****

Investors

Amadeus Capital & 21 more

Ranked

2^nd among 115 active competitors

Employee Count

117 as on Jul 31, 2026

Similar Companies

AIdoc & 445 more

View Quibim's full profile

Quibim is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
QUIBIM, S.L CIN: 1626656 , Spain, Active	Apr 23, 2021	-	-	-
QUIBIM LIMITED CIN: 14023736 , United Kingdom, Active	Apr 03, 2022	-	2 (As on Dec 31, 2024)
QUIBIM INC. CIN: 7592503 , United States, Active	Sep 05, 2019	-	3 (As on Dec 01, 2023)	-

Quibim has raised a total funding of $60M over 15 rounds. Its first funding round was on Jul 27, 2016. Its latest funding round was a Series A round on Jan 28, 2025 for $*****. 11 investors participated in its latest round. Quibim has 20 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Quibim:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 28, 2025	1592920	Series A	7920625	1654359	7851907	5454838
Oct 01, 2020	6041769	Grant (prize money)	8022674	8688706	3197947	Europa
Sep 01, 2020	3771903	Grant (prize money)	9764159	8176062	3943028	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Quibim's funding rounds and investors

The founders of Quibim are Angel Alberich-Bayarri and Luis Marti-Bonmati. Angel Alberich-Bayarri is the CEO of Quibim.

Here are the details of Quibim's key team members:

Angel Alberich-Bayarri: Co-Founder & CEO of Quibim.
Contact Info: 1 email address
Luis Marti-Bonmati: Co-Founder of Quibim.
Contact Info: 1 email address

View details of Quibim's Founder profiles and Board Members

Quibim's employee count trend

Quibim has 117 employees as of Jul 26. Here is Quibim's employee count trend over the years:

Uncover Quibim's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Quibim include AOA, Median and Panakeia. Here is the list of Top 10 competitors of Quibim, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AOA 2019, Boston (United States), Series A	Provider of an AI-enabled early detection platform focused on womens health	$40.7M	Y Combinator, Good Growth Capital & 32 others	60/100
2nd	Quibim 2015, Valencia (Spain), Series A	Developer of medical imaging software for radiomics and biomarker analysis	$60M	Partech Partners, Philips HealthWorks & 20 others	59/100
3rd	Median 2002, Valbonne (France), Public	Provider of medical imaging software and services for clinical trials usage	$5.28M	Auriga Partners, Abingworth & 6 others	58/100
4th	Panakeia 2018, London (United Kingdom), Seed	Provider of AI-based software for diagnosis and precision treatment	$3.79M	LocalGlobe, Entrepreneur First & 4 others	56/100
5th	SquareMind 2019, Paris (France), Seed	Developer of robotic medical equipment for skin cancer detection	$18M	Sonder Capital, Adamed Technology & 7 others	53/100
6th	Spotitearly 2020, Tel Aviv (Israel), Seed	AI-based cancer detection device for providers	$26.5M	Hanaco Ventures & 5 others	53/100
7th	Modicus Prime 2020, La Porte (United States), Seed	Provider of an AI-based decision-making tool for healthcare professionals	$8M	Frist Cressey Ventures, Silverton Partners ... & 6 others	52/100
8th	VirtualScopics 2000, Rochester (United States), Acquired	Provider of imaging-based clinical trial solutions	$3.8M	Merck Global Health Innovation Fund, Ravensbridge Capital ... & 3 others	48/100
9th	Astrin 2021, Saint Paul (United States), Series B	AI-empowered 3D holographic imaging platform for early cancer detection	$22.9M	HHS	47/100
10th	IAG 2007, London (United Kingdom), Funding Raised	Imaging clinical research platform providing drug safety & efficacy in early phase trials	-	RBV Capital, Biovision Ventures	45/100